Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Panacea Biotec Ltd. Regulatory Filings 2021

Jul 2, 2021

62573_rns_2021-07-02_1fdea451-af9e-478e-88e2-1369d211b6bf.pdf

Regulatory Filings

Open in viewer

Opens in your device viewer

July 02, 2021

The Manager, Listing Department The National Stock Exchange ofIndia Ltd. Exchange Plaza, Bandra Kurla Complex, Bandra (E), Mumbai - 400 051 NSE Symbol: PANACEABIO

BSE Limited Corporate Relationship Department, Phiroze Jeejeebhoy Towers, Dalal Street, Mumbai - 400 001 BSE Scrip Code: 531349

Sub: Disclosure under Regulation 23(9) of the Securities and Exchange Board ofIndia (Listing Obligations and Disclosure Requirements) Regulations, 2015

Dear Sir/Madam,

Pursuant to Regulation 23(9) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed disclosure of related party transactions in the format specified in the relevant accounting standards for half year ended March 31, 2021 on consolidated basis.

This is for your kind information and record please.

Thanking you,

Sincerely yours, For Panacea Biotec Ltd.

Encls.: As Above

B1 Extn./G3, Mohan Co-op Indl. Estate, Mathura Road, New Delhi -110044 Email: [email protected] Phone: 0.1.0. +91-11-41679015 Fax: +91-11-41679070

Panacea Biotec Ltd.

CIN:L33117PB1984PLC022350 Registered Office: Ambala-Chandigarh Highway, Lalru - 140501, Punjab, India. Ph.: +91-1762-505900, Fax: +91-1762-505906. e-mail: [email protected] website: www.panaceabiotec.com

Disclosure of Related Party Transactions on Consolidated Basis - Half year ended March 31, 2021

[In pursuance with Regulation 23(9) ofSEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015]

A. Names of related parties and related party relationships

i) Parties where control exists:

Subsidiaries

  • Panacea Biotec (International) SA ("PBS"), Switzerland (WOS)
  • Panacea Biotec Germany GmbH, Germany (IWOS through PBS)
  • Panacea Biotec Pharma Limited (WOS)
  • Meyten Realtech Private Limited (WOS)
  • Pan Era Biotec Private Limited \$
  • Adveta Power Private Limited \$

ii) Other related parties:

  • a) Joint Ventures:
  • Chiron Panacea Vaccines Private Limited (Under liquidation)
  • b) Key Management Personnel:

• Mr. Soshil Kumar Jain

• Dr. Rajesh Jain • Mr. Sandeep Jain • Mrs. Sunanda Jain • Mr. Sum it Jain • Mr. Ankesh Jain • Mr. Ashwini Luthra • Mr. Bhupinder Singh

• Mr. K. M. Lal

Nalavadi • Mr. Vinod Goel • Mr. Devender Gupta

• Mrs. Manjula Upadhyay • Mr. Mukul Gupta • Mr. N. N. Khamitkar • Mr. R. L. Narasimhan • Mr. Shantanu Yeshwant

  • Chairman and Whole-time Director
  • Managing Director
  • Joint Managing Director
  • Whole-time Director (upto October 07, 2020)
  • Whole-time Director (upto October 07, 2020)
  • Whole-time Director
  • Non-Executive Independent Director
  • Non-Executive Independent Director
  • Non-Executive Independent Director
  • Non-Executive Independent Director
  • Non-Executive Independent Director
  • Non-Executive Independent Director
  • Non-Executive Independent Director
  • Nominee Director
  • Group CFO and Head Legal & Company Secretary
  • Chief Financial Officer & Head Information Technology
  • c) Relatives of Key Management Personnel:
  • Mr. Ashwani Jain, son-in-law of Mr. Soshil Kumar Jain
  • Mr. Shagun Jain, son-in-law of Mrs. Sunanda Jain (upto October 07,2020)
  • Mrs. Radhika Jain, daughter of Mrs. Sunanda Jain and sister of Mr. Sumit Jain (upto October 07, 2020)
  • Mrs. Shilpy Jain, wife of Mr. Sumit Jain and daughter-in-law of Mrs. Sunanda Jain (upto October 07,2020)
  • Mr. Harshet Jain, son of Dr. Rajesh Jain and brother of Mr. Ankesh Jain

S considered as subsidiary for the purpose of consolidation as per Ind AS I I 0

  • d) Enterprises over which Person(s) (having control or significant influence over the Company / Key Management Personnel(s), along with their relatives) are able to exercise significant influence:
  • Ravinder Heights Limited #
  • Radhika Heights Limited #
  • Cabana Construction Private Limited #
  • Cabana Structures Limited #
  • Nirmala Buildwell Private Limited #
  • Nirmala Organic Farms & Resorts Private Limited #
  • Radicura Infra Limited #
  • Sunanda Infra Limited #
  • Neophar Alipro Limited
  • Lakshmi & Manager Holdings Limited ("LMH") (upto October 07, 2020)
  • Trinidhi Finance Private Limited (subsidiary ofLMH) (upto October 07,2020)
  • Best General Insurance Company Limited (subsidiary ofLMH) (upto October 07,2020)
  • First Lucre Partnership Co. (holding shares in the Company)
  • White Pigeon Estate Private Limited (upto October 07, 2020)
  • OKI Estates Private Limited (upto October 07, 2020)
  • Panacea Life Sciences Limited (upto October 07,2020)
  • MD Next Life Sciences LLP (w.e.f. April 08, 2020)

# Wholly owned subsidiary until September 10,.2020.

B. Transactions and Outstanding Balances with Related Parties

Transactions and balances with its own Subsidiaries/Sub-subsidiaries are eliminated on consolidation

(Rs, in million)
S. Particulars Joint Ventures Key Management Enterprises over which Person(s)
No. Personnel/Relatives (having control or significant
of Key Management influence over the Company / Key
Personnel Management Personnel(s),
along
with their relatives) are able to
exercise significant influence
J) Transactions made during the half year ended March 31,2021
1 Remuneration:
Mr. Soshil Kumar Jain 5.45
Dr. Rajesh Jain 3.65
Mr. Sandeep Jain 3.54
Mrs. Sunanda Jain (upto October 07, 2020) 0.10
Mr. Sumit Jain (upto October 07, 2020) 0.10
Mr. Ankesh Jain 1.35
Mr. Vinod Goel 2.56
Mr. Devender Gupta 1.81
Mr. Ashwani Jain 1.48
Mrs. Radhika Jain (upto October 07,2020) 0.00
Mr. Harshet Jain 0.33
2 Post - employment benefits:
Mr. Soshil Kumar Jain 17.15
Dr. Rajesh Jain 9.46
Mr. Sandeep Jain 8.60
Mrs. Sunanda Jain 0.96
Mr. Sumit Jain 2.63
Mr. Ankesh Jain 0.80
Mr. Vinod Goel 1.57
Mr. Devender Gupta 0.91
Mr. Ashwani Jain 2.00
Mrs. Radhika Jain (upto October 07, 2020) 0.00
Mr. Harshet Jain 0.02
3 Fee for attending Board/Committee Meetings:
Mr. Ashwini Luthra - 0.10
Mr. Bhupinder Singh - 0.10
Mr. K. M. Lal - 0.14
Mrs. Manjula Upadhyay - 0.05
Mr. Mukul Gupta - 0.10
Mr. N. N. Khamitkar - 0.13
Mr. R. L. Narasimhan - 0.13
4 Rent Income :
Neophar .Alipro Limited
Radhika Heights Limited 0.09
Ravinder Heights Limited 0.04
Chiron Panacea Vaccines Private Limited (Under 0.01
liquidation) 0.18

s.
No.
Particulars Joint Ventures Key Management
Personnel/Relatives
of Key Management
Personnel
Enterprises over which Person(s)
(having control or significant
influence over the Company / Key
Management Personnel(s), along
with their relatives) are able to
exercise significant influence
5 Rent & Other expenses :
Radhika Heights Limited
- - 3.08
6 Interest expenses :
Mr. Soshil Kumar Jain - 6.41 -
Dr. Rajesh Jain - 8.45 -
Mrs. Sunanda Jain - 1.02 -
Radhika Heights Limited - - 9.21
7 Consultancy expenses:
Mrs. Sunanda Jain - 1.05
Mr. Sumit Jain - 1.00 -
-
Mrs. Shilpy Jain (upto October 07,2020) - 0.00 -
8 Loan received:
Dr. Rajesh Jain - 10.00 -
II) Year end balances
1 Loan Payable:
Mr. Soshil Kumar Jain - 125.21 -
Dr. Rajesh Jain - 172.02 -
Mrs. Sunanda Jain - 21.57 -
Radhika Heights Limited - - 245.03
2 Interest Payable:
Mr. Soshil Kumar Jain - 22.14
Dr. Rajesh Jain - 23.89 -
-
3 Outstanding Receivable:
Radhika Heights Limited - - 0.99
Trinidhi Finance Private Limited - - 0.10
Ravinder Heights Limited - - 0.09
4 Outstanding Payable:
Radhika Heights Limited - - 8.91
Mrs. Shilpy Jain - 0.05 -
Mrs. Sunanda Jain - 0.21 -
Mr. Sumit Jain - 0.20 -

Note: 0.00 under "Rs. III million" represents amount less than or equal to Rs.50,000.